Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute [corrected] stroke thrombolysis: an update [corrected].

Manu Mehdiratta1, Louis R Caplan

  • 1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Progress in Cardiovascular Diseases
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locked-in syndrome.

Handbook of clinical neurology·2026
Same author

Transient ischemic attack in the twenty first century: is it still a useful construct?

Frontiers in stroke·2026
Same author

Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.

Lancet (London, England)·2025
Same author

Risk of major vascular events in patients without traditional risk factors after transient ischemic attack or minor ischemic stroke: An international prospective cohort.

European stroke journal·2024
Same author

Time Windows Between Symptom Onset and Treatment-An Outdated Myth.

JAMA neurology·2024
Same author

Frequency of Intubation for Medicare Beneficiaries With Acute Stroke and Association With Patient Outcomes.

Neurology·2024

Intravenous tissue plasminogen activator (t-PA) has advanced acute stroke therapy since 1996. Despite improved treatments and devices, thrombolytic use in eligible stroke patients remains low, necessitating a review of current practices.

Area of Science:

  • Neurology
  • Cardiology
  • Emergency Medicine

Background:

  • The 1996 FDA approval of intravenous tissue plasminogen activator (t-PA) marked a significant advancement in acute stroke treatment.
  • Since t-PA's approval, substantial progress has been made in neuroimaging and device technology for acute stroke management.

Observation:

  • Despite therapeutic advancements, the administration rate of thrombolytics to eligible acute stroke patients in the US remains low, between 3% and 8%.

Findings:

  • This review examines thrombolytic therapy for stroke, highlighting key imaging innovations and emerging devices.
  • Recent clinical trials are reshaping contemporary acute stroke treatment paradigms.

Implications:

  • A practical management approach for acute stroke is presented, tailored for cardiologists encountering stroke in various clinical scenarios.

Related Experiment Videos

  • Understanding these advancements is crucial for optimizing acute stroke care and improving patient outcomes.